Skip to main content
. 2018 Jun 29;9(50):29445–29452. doi: 10.18632/oncotarget.25655

Figure 2.

Figure 2

Kaplan-Meier plots for DFS (in months) stratified for MACROD2-high and MACROD2-low protein expression in stage II (A-C) and stage III (D-F) colon cancer patients including the subset of MSS (B, E) and MSI (C, F) patients. Log-rank p-values and Cox regression hazard ratios (HRs) with 95% confidence intervals (CIs) are reported.